Clinical use
Atenolol is a β1 receptor antagonist, for treating cardiovascular disease. Monitoring adequacy of blood concentration of atenolol during therapy. The test may also be useful to evaluate patient compliance.
Background
Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of β-blockers, a class of drugs used primarily in cardiovascular diseases. The chemical works by slowing down the heart and reducing its workload. Atenolol does not pass through the blood-brain barrier thus avoiding various CNS side effects. Atenolol is one of the most widely used β-blockers in the United Kingdom and was once the first-line treatment for hypertension.
Reference ranges
0.5 – 2.8 mg/L
Patient preparation
None required
Specimen requirements
Serum, plain (Red top tube). SST samples are not suitable.
Turnaround time
1 week
Additional Information
Not routinely measured. Check with biochemist before referring sample.
Referred test
Referred test
Location
Toxicology laboratory
